Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation

Leukemia ◽  
2015 ◽  
Vol 30 (4) ◽  
pp. 812-822 ◽  
Author(s):  
V Tosello ◽  
F Bordin ◽  
J Yu ◽  
V Agnusdei ◽  
S Indraccolo ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Protein Degradation ◽  
Lymphoblastic Leukemia ◽  
Leukemia Cells ◽  
Inhibitor Of Apoptosis ◽  
Inhibitor Of Apoptosis Protein ◽  
Apoptosis Protein ◽  
Cell Acute Lymphoblastic Leukemia

scholarly journals CD 47 agonist peptide PKHB 1 induces immunogenic cell death in T‐cell acute lymphoblastic leukemia cells

2018 ◽  
Vol 110 (1) ◽  
pp. 256-268 ◽  
Author(s):  
Ashanti Concepción Uscanga‐Palomeque ◽  
Kenny Misael Calvillo‐Rodríguez ◽  
Luis Gómez‐Morales ◽  
Eva Lardé ◽  
Thomas Denèfle ◽  
...  
Keyword(s):  
Cell Death ◽  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Lymphoblastic Leukemia ◽  
Leukemia Cells ◽  
Immunogenic Cell Death ◽  
Agonist Peptide ◽  
Cell Acute Lymphoblastic Leukemia

scholarly journals PS924 A DRUG SCREEN TO STUDY THE EFFECT OF EPIGENETIC INHIBITORS ON T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CELLS

HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 416
Author(s):  
C. Prieto ◽  
M. Broux ◽  
S. Demeyer ◽  
L. Albertí-Servera ◽  
K. Jacobs ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Lymphoblastic Leukemia ◽  
Leukemia Cells ◽  
Drug Screen ◽  
Cell Acute Lymphoblastic Leukemia

Targeted delivery of vincristine to T-cell acute lymphoblastic leukemia cells using an aptamer-modified albumin conjugate

RSC Advances ◽  
2016 ◽  
Vol 6 (52) ◽  
pp. 46366-46371 ◽  
Author(s):  
Seyed Mohammad Taghdisi ◽  
Noor Mohammad Danesh ◽  
Mohammad Ramezani ◽  
Khalil Abnous
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Clinical Application ◽  
Targeted Delivery ◽  
Lymphoblastic Leukemia ◽  
Leukemia Cells ◽  
Poor Solubility ◽  
Cell Acute Lymphoblastic Leukemia

Clinical application of vincristine in treatment of cancer is restricted because of its poor solubility and neuropathy.

scholarly journals TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells

Leukemia ◽  
2011 ◽  
Vol 25 (10) ◽  
pp. 1578-1586 ◽  
Author(s):  
B A Cardoso ◽  
S F de Almeida ◽  
A B A Laranjeira ◽  
M Carmo-Fonseca ◽  
J A Yunes ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukemia ◽  
T Cell ◽  
Histone Deacetylase ◽  
Lymphoblastic Leukemia ◽  
Leukemia Cells ◽  
Histone Deacetylase Inhibition ◽  
Cell Acute Lymphoblastic Leukemia
Sign in / Sign up

Export Citation Format

Share Document